In patients with suspected MI with no obstructed coronary arteries, a stratified treatment protocol was superior to standard ...
Standard laboratory tests can fail to detect many disease-causing DNA changes. Now, a novel 3D chromosome mapping method can ...
“Our expansion into Dallas advances our mission to make fast, accurate toxicology testing more accessible,” said Michael Blaksley, CEO of Monarch Diagnostics. “We’re proud to bring our services to ...
Standard laboratory tests can fail to detect many disease-causing DNA changes. Now, a novel 3D chromosome mapping method can ...
The VasCog-2-WSO criteria revise the original VasCog criteria for diagnosing VCID, offering additional guidance on neuroimaging and fluid biomarkers.
Among public and private players, RadNet ( NYSE: RDNT ) stands out as a “picks and shovels” success story. With nearly 400 ...
Designed for investors, board members, and CEOs, the latest PatentVest Pulse report offers a strategic view of who’s leading and why in the rapidly evolving cardiac diagnostics market ...
At the annual session of the American College of Cardiology (ACC 2025), a study was presented showing that the use of AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback